Yi Ba

22.3k citations

209 papers · 7.8k · 4 hit papers · h-index 45

Impact in

Cancer Research top 0.1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology top 1%
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
- RNA Interference and Gene Delivery

Papers in

Oncology 76
- Colorectal Cancer Treatments and Studies 34
- Cancer Immunotherapy and Biomarkers 16
Molecular Biology 53
- Circular RNAs in diseases 18

Co-authors: Ting Deng (67 shared papers)Haiyang Zhang (42 shared papers)Guoguang Ying (24 shared papers)Haiou Yang (9 shared papers)Tao Ning (32 shared papers)Jialu Li (12 shared papers)Shaohua Ge (36 shared papers)Tao Ning (15 shared papers)
Journals: Journal of Clinical Oncology (43 papers)BMC Cancer (6 papers)Scientific Reports (5 papers)Annals of Oncology (4 papers)Oncotarget (4 papers)
Partner nations: China United States Japan

In The Last Decade

Yi Ba

199 papers receiving 7.7k citations

Yi Ba's Hit Papers

align trajectories log scale

Adipocyte‐Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer 2022 · 170 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Advanced Science
2020 Molecular Cancer
2020 Molecular Oncology
2017 Nature Communications

Peers

Countries citing papers authored by Yi Ba

Since Specialization

Citations

This map shows the geographic impact of Yi Ba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ba more than expected).

Fields of papers citing papers by Yi Ba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Ba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ba. The network helps show where Yi Ba may publish in the future.

Co-authors

The 25 scholars most cited alongside Yi Ba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yi Ba Line = papers co-authored together Yi Ba links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 209 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer Molecular Cancer ·Haiyang Zhang, Ting Deng, Rui Liu, Tao Ning, Haiou Yang, Dongying Liu, Qiumo Zhang, Dan Lin, Shaohua Ge, Ming Bai, Xinyi Wang, Le Zhang, Hongli Li, Yuchong Yang, Zhi Ji, Hailong Wang, Guoguang Ying, Yi Ba Hit paper breakdown →	2020	809
2	Role of miR-143 targeting KRAS in colorectal tumorigenesis Oncogene ·Xiaoli Chen, Xu Guo, Hao Zhang, Yang Xiang, J. Chen, (unknown), Xianwei Cai, Kang Wang, Gaohong Wang, Yi Ba, Lin Zhu, Jie Wang, Rong Yang, Ying E. Zhang, Z. Ren, K Zen, J. Zhang, C-Y Zhang	2009	473
3	Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis Nature Communications ·Haiyang Zhang, Ting Deng, Rui Liu, Ming Bai, Likun Zhou, Xia Wang, Shuang Li, Xinyi Wang, Haiou Yang, Jialu Li, Tao Ning, Dingzhi Huang, Hongli Li, Le Zhang, Guoguang Ying, Yi Ba Hit paper breakdown →	2017	455
4	Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer Molecular Oncology ·Xinyi Wang, Haiyang Zhang, Haiou Yang, Ming Bai, Tao Ning, Ting Deng, Rui Liu, Qian Fan, Kegan Zhu, Jialu Li, (unknown), Guoguang Ying, Yi Ba Hit paper breakdown →	2020	425
5	A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis European Journal of Cancer ·Rui Liu, (unknown), (unknown), Zhibin Hu, Li Gou, Cheng Wang, Cuihua Yang, Dingzhi Huang, Xi Chen, Haiyang Zhang, Rui Zhuang, Ting Deng, Hua Liu, Jingjing Yin, Sufen Wang, Ke Zen, Yi Ba, Chen-Yu Zhang	2010	350
6	Serum MicroRNA Expression Profile as a Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer Clinical Chemistry ·Rui Liu, Xi Chen, Yiqi Du, Weiyan Yao, Lin Shen, Cheng Wang, Zhibin Hu, Rui Zhuang, Guang Ning, (unknown), Yaozong Yuan, Zhao‐Shen Li, Ke Zen, Yi Ba, Chen-Yu Zhang	2011	327
7	RNA-Seq Technology and Its Application in Fish Transcriptomics OMICS A Journal of Integrative Biology ·Xi Qian, Yi Ba, Qianfeng Zhuang, Guofang Zhong	2013	259
8	Identification of ten serum microRNAs from a genome‐wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis International Journal of Cancer ·Xi Chen, Zhibin Hu, Wenjing Wang, Yi Ba, Lijia Ma, (unknown), Cheng Wang, Zhiji Ren, Yang Zhao, Sijia Wu, Rui Zhuang, Yixin Zhang, Heng Hu, Chazhen Liu, Lin Xu, Jun Wang, Hongbing Shen, Junfeng Zhang, Ke Zen, Chen‐Yu Zhang	2011	240
9	Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer Molecular Therapy ·Xinyi Wang, Haiyang Zhang, Ming Bai, Tao Ning, Shaohua Ge, Ting Deng, Rui Liu, Le Zhang, Guoguang Ying, Yi Ba	2018	183
10	Adipocyte‐Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer Advanced Science ·Qiumo Zhang, Ting Deng, Hongdian Zhang, Duo Zuo, Qihang Zhu, Ming Bai, Rui Liu, Tao Ning, Le Zhang, Zhentao Yu, (unknown), (unknown), Yi Ba Hit paper breakdown →	2022	170
11	Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis Theranostics ·Haiou Yang, Haiyang Zhang, Yuchong Yang, Xinyi Wang, Ting Deng, Rui Liu, Tao Ning, Ming Bai, Hongli Li, Kegan Zhu, Jialu Li, Qian Fan, Guoguang Ying, Yi Ba	2020	163
12	miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer Molecular Cancer ·Xin Yan, Xi Chen, Hongwei Liang, Ting Deng, Weixu Chen, Suyang Zhang, M. Liu, Xiujuan Gao, Yanqing Liu, Chihao Zhao, Xueliang Wang, Nan Wang, Jialu Li, Rui Liu, Ke Zen, Chen-Yu Zhang, Baorui Liu, Yi Ba	2014	145
13	Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA Cancer Science ·Haiyang Zhang, (unknown), Ming Bai, Junyi Wang, Kegan Zhu, Rui Liu, Shaohua Ge, Jialu Li, Tao Ning, Ting Deng, Qian Fan, Hongli Li, Wu Sun, Guoguang Ying, Yi Ba	2017	127
14	Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer Molecular Therapy ·Tao Ning, Jialu Li, Yi He, Haiyang Zhang, Xinyi Wang, Ting Deng, Rui Liu, Hongli Li, Ming Bai, Qian Fan, Kegan Zhu, Guoguang Ying, Yi Ba	2021	127
15	The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer Theranostics ·Wu Sun, Jialu Li, Likun Zhou, Jiayi Han, Rui Liu, Haiyang Zhang, Tao Ning, Zhiying Gao, Baorui Liu, Xi Chen, Yi Ba	2020	108
16	Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial The Lancet Oncology ·Rui‐Hua Xu, Kei Muro, Satoshi Morita, Satoru Iwasa, Sae Won Han, Wei Wang, Masahito Kotaka, Masato Nakamura, Joong Bae Ahn, Yan‐Hong Deng, Takeshi Kato, Sang‐Hee Cho, Yi Ba, Hiroshi Matsuoka, Keun‐Wook Lee, Tao Zhang, Yasuhide Yamada, Junichi Sakamoto, Young Suk Park, Tae Won Kim	2018	101
17	Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma Cancer Letters ·Haiyang Zhang, Ming Bai, Ting Deng, Rui Liu, Xia Wang, Yanjun Qu, Jingjing Duan, Le Zhang, Tao Ning, Shaohua Ge, Hongli Li, Likun Zhou, Yuchen Liu, Dingzhi Huang, Guoguang Ying, Yi Ba	2016	98
18	Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial Chinese Journal of Cancer ·Zhong-Zhen Guan, Jian-Ming Xu, Rong-Cheng Luo, Feng-yi Feng, Li-Wei Wang, Lin Shen, Shiying Yu, Yi Ba, Jun Liang, Dong Wang, (unknown), Jiejun Wang, Jing He, Chuan Qi, Rui‐Hua Xu	2011	97
19	<p>Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer</p> International Journal of Nanomedicine ·Qiumo Zhang, Haiyang Zhang, Tao Ning, Dongying Liu, Ting Deng, Rui Liu, Ming Bai, Kegan Zhu, Jialu Li, Fan Qian, (unknown), Yi Ba	2020	97
20	MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway Cell Death and Disease ·Wu Sun, Xiaojun Wang, Jialu Li, Chaoying You, Lu Pan, Huijin Feng, Yan Kong, Haiyang Zhang, Yanqing Liu, Rui‐Hua Jiao, Xi Chen, Yi Ba	2018	83

About Yi Ba

Yi Ba is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 209 papers that have together received 7.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (38 papers), Colorectal Cancer Treatments and Studies (34 papers), Gastric Cancer Management and Outcomes (32 papers), Cancer-related molecular mechanisms research (25 papers), Circular RNAs in diseases (18 papers), Esophageal Cancer Research and Treatment (17 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Lung Cancer Treatments and Mutations (12 papers). The work is most often cited by research in Cancer Research (4.0k citations), Molecular Biology (4.6k citations), Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.1k citations) and Immunology (522 citations). Yi Ba has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Ting Deng, Haiyang Zhang, Guoguang Ying, Haiou Yang, Tao Ning, Jialu Li, Shaohua Ge, Tao Ning, Rui Liu and Dingzhi Huang. Their work appears in journals such as Journal of Clinical Oncology, BMC Cancer, Scientific Reports, Annals of Oncology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Yi Ba

Impact in

Papers in i

In The Last Decade

Yi Ba

Yi Ba's Hit Papers

Peers

Countries citing papers authored by Yi Ba

Fields of papers citing papers by Yi Ba

All Works

About Yi Ba

Explore authors with similar magnitude of impact

Papers in